Atlas Trials

Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Clinical trial NCT01919801 · COMPLETED

Trial details

NCT number
NCT01919801
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Start date
2013-12-02
Primary completion
2015-08-22
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.